SPX3,998.84-72.86 -1.79%
DIA340.03-4.71 -1.37%
IXIC11,239.94-221.56 -1.93%

Mizuho Maintains Buy on Assembly Biosciences, Lowers Price Target to $3

Benzinga · 11/16/2022 08:29
Mizuho analyst Salim Syed maintains Assembly Biosciences (NASDAQ:ASMB) with a Buy and lowers the price target from $14 to $3.